STANISLAUS CONNECTIONS
Working For Peace, Justice, and A Sustainable Environment
June, 2001
A Modesto Peace/Life Center Publication
HIV/AIDS in Africa
Aids
in Africa:
A GENERATION AT RISK
The
African AIDS crisis staggers the imagination. Six thousand Africans die daily,
making it the worst infectious disease calamity since the Plague of the Middle
Ages. More persons will die of AIDS in Africa over the next decade than have
died from all the world’s wars of the 20th century. Many AIDS victims have
done nothing more harmful than enter the world — 12.1 million African children
have been orphaned by AIDS. For them the tragedy is only beginning, since many
have or are likely to contract the disease. As an entire generation disappears
before our eyes, church groups, private agencies and caring people worldwide and
in Africa struggle to find effective responses to this catastrophe.
...
We are one world, and these children are our children. Their destiny is our
destiny. Each of us can make a difference. Each of us can help save lives. Let
us wage this holy war together. And for the sake of our children, we will win.
— Bishop Desmond Tutu
AN
AFRICAN PLAGUE
Africa
has 10 percent of the world’s population, but 70 percent of global
HIV/AIDS cases.
85
percent of all AIDS-related deaths were in Africa last year, yet less than 5
percent of Africans know their HIV status. UNAIDS
Today
there are 23.5 million African women and men infected with HIV/AIDS, plus
another one million children.
In
sub-Saharan Africa 470,000 children die each year from AIDS. Over 90 percent
of them contracted the disease from their mothers.
New
AIDS cases diagnosed each year: USA - 40,000 Africa - 5.6 million
AIDS
kills more Africans than war, and more wars are being fought there than on
any other continent.
The
U.S. Census Bureau estimates life expectancy in sub-Saharan Africa will fall
to around age 30 within a decade — the lowest in a century.
90
percent of all HIV transmission in Africa occurs through heterosexual sex.
This is 100 percent preventable.
Malawian
women with AIDS.
The
National Community of Women Living with AIDS in Uganda created a special project
— the Memory Book. Mothers write their life story in the book with family
photos and talk about where they came from, experiences they’ve had.
“And
they talk about their children because, you see, they want to leave these books
for their kids, so that when they are gone — and they know that day is coming
— their children will have this memory book to look at. I sat on the porch
there as two mothers read to me from their books. I realized then that I was in
a nation that had turned into a hospice.” — Sen. Richard Durbin
A
GENERATION OF ORPHANS
Without
significant intervention, by 2010 there will be 40 million AIDS orphans in
Africa, most of whom will have grown up with little or no social structure. That
is equal to all the children attending public schools in the USA today.
Orphans
are at far greater risk of malnutrition and unlikely to receive the health care
or education they need. They are also more likely to engage in hazardous labor,
including commercial sex work, which in turn exposes them to greater risk of HIV
infection.
AIDS
has wiped out decades of progress in improving the lives and health of families
in Africa — infant mortality is doubling, child mortality is tripling, and
life expectancy is plummeting by twenty years or more.
Poverty-stricken
African health systems are being overwhelmed by AIDS. Up to 50 percent of
hospital beds are occupied by HIV/AIDS patients in many parts of sub-Saharan
Africa.
CONTRIBUTING
FACTORS:
Status
of Women:
Economic dependency and social norms make it hard for women and girls to deny
men sex. Women account for 55 percent of the continent’s HIV infections.
Teenage girls suffer 5 to 6 times the infection rates of boys because older men
prey on them. At the same time, women and girls tend to bear the main burden of
caring for sick family members, and often have less care and support when they
are infected.
Poverty/Debt:
95 percent
of Africans infected with HIV/AIDS live in abject poverty, with no hope of
obtaining the new drugs that patients in developed countries use to combat the
virus and lead comparatively normal lives. Half of Africa’s population lack
access to safe drinking water, two-thirds lack access to adequate sanitation.
African nations are forced to spend four times more on repaying their foreign
debt than on health care or education.
Wars/Refugees:
Soldiers often visit commercial sex workers — 90 percent of whom are believed
to have AIDS. Civil conflict, displaced populations and increasing interventions
by the armed forces of African nations further spread the disease. People are
six times more likely to contract HIV in a refugee camp than in the outside
population.
Fear
and Denial:
The stigma associated with AIDS prevents open discussion and diminishes support
systems. Thandiwe Mwandla, a South African woman with AIDS, found that when her
diagnosis was known, no one would buy her sugar cane or anything else she had
touched. Her neighbors walked around her. She notes, “We get sick, and we get
poor, and we die lying to ourselves.”
Cultural
Factors:
Polygamy and unsafe sexual practices are key factors. Since most men are not
tested, they can unknowingly spread the disease. Many men believe sex with a
virgin will cure AIDS, prompting them to target younger and younger girls.
Compounding the problem is a common belief among women that if a man looks
healthy, he couldn’t have AIDS.
THE
ROAD TO RECOVERY
My
friend with AIDS is still my friend. --South African Bumper sticker
Despite
staggering statistics, significant progress is being made against AIDS by
churches, governments and community organizations banding together to break the
silence, challenge behavior, and provide basic care to those in need.
A
tree of hope:
Research conducted by Church World Service (CWS) in Senegal has demonstrated
that the Moringa tree, native to tropical regions, is a fountain of vitamins and
minerals. Gram for gram, Moringa leaves contain three times the iron of spinach,
four times the vitamin A of carrots, seven times the vitamin C of oranges. It
can also be used to clarify water, treat diabetes, and cure skin infections. CWS
has launched a major initiative to promote the use of Moringa as a nutritional
supplement throughout Africa.
Leading
the way:
Ethiopian community-based and religious organizations are at the forefront of
the fight against AIDS in that country. For example, the Ethiopian Orthodox
Church (a CWS partner) organizes public rallies, youth workshops, counseling,
and street theater to raise awareness and encourage abstinence from premarital
sex. Since those carrying the disease are often discriminated against, sometimes
losing their employment, the church provides money and training for
income-generating projects. They have joined forces with Catholics, Evangelicals
and Muslims to create a joint interfaith effort to curb the disease.
“AIDS
doesn’t care about what your religion is,” commented one resident of Rakai,
a Ugandan province with one of the highest HIV incidence rates in the world. In
the face of desolate villages, fallow fields and abandoned orphans, Lutheran
World Federation initiated a rehabilitation and development program in 1992.
Clinics were established, roads and schools repaired, and school teachers were
educated as health instructors. But to ensure full community participation,
local religious leaders needed to cooperate. Overcoming generations of tension,
the Muslim District Khaddi and the Anglican and Catholic bishops agreed to meet,
pray and work together. The number of HIV/AIDS cases has dropped substantially,
and their model program is now shown to visitors from around the world.
WHAT
CAN I DO?
Support
Church World Service or other organizations fighting AIDS in Africa. Visit www.churchworldservice.org
Learn
more about the African AIDS crisis from the CWS Video and Film Library. For
a complementary catalogue of free-loan videos, call or write: CWS Film
Library, P.O. Box 968, Elkhart, IN 46515; 800-297-1516 or consult our website
.
Exercise
Your Citizenship: UNAIDS estimates it will take $3 billion to establish
effective AIDS prevention programs in Africa, about what is spent on health
care in the U.S. every day. Contributions from donor nations equal only
about one tenth that amount. Write your Representative and Senators urging
financial support of meaningful AIDS legislation.
Support
those in your own community struggling with AIDS.
Examine
your own attitudes toward those with AIDS.
SOURCES
FOR FURTHER LEARNING
“AIDS:
Africa in Peril.” CNN.Com, www.cnn.com/SPECIALS/2000/aids/
AIDS
in Africa: Heartbreak and Hope. United Methodist Website: http://gbgm-umc.org/programs/aidsafrica/newsfacts.stm
Report
on the Global AIDS Epidemic: June 2000. UNAIDS. www.unaids.org/epidemic_update/report/Epi_report.pdf
AIDS
Clock: www.unfpa.org/modules/aidsclock/intro.htm
Big
Pharma and the global response to HIV/AIDS
By
RUSSELL MOKHIBER and ROBERT WEISSMAN
One
of the perquisites of power is that the powerful can always command a fresh
start. Past crimes and misdemeanors, and even current misdeeds, are not held
against them.
Consider
the case of the pharmaceutical industry and the issue of access to HIV/AIDS and
other essential medicines.
The
rich countries are now, belatedly, gearing up to commit some substantial monies
to address HIV/AIDS in Africa and elsewhere in the developing world. The
brand-name pharmaceutical companies are jockeying for a central role in
determining how those monies are spent. And, unless sufficient public opposition
emerges, they are likely to secure it.
There
is now no serious dispute that the brand-name pharmaceutical companies have
worked overtime to deny poor countries access to lifesaving medicines.
The
industry insistence in maintaining its lawsuit challenging South Africa’s
Medicines Act helped forge a broad, worldwide consensus — from the New York
Times to the European Parliament — against the industry’s role in
interfering with poor countries’ efforts to promote access to essential
medicines. International condemnation forced the industry to back down in the
suit, but the South Africa case was only one of many instances where the
industry has played a pernicious role. Big Pharma’s obsession has been to
block the introduction of generic competition — which has the potential to
bring drug prices down by 95 percent or more — and it has employed misleading
propaganda campaigns, threats of litigation, promises of trade sanctions, and
new trade agreements to advance its aims.
Against
this backdrop comes a set of proposals for a global AIDS fund, or a global
tropical disease fund. In late June, the United Nations will hold a special
session on HIV/AIDS. Then the elite rich countries, grouped together in the G8,
will meet in Genoa, Italy, in July. There is widespread expectation that the
rich countries will agree to a framework for a new fund, and make preliminary
dollar commitments. UN Secretary General Kofi Annan has requested contributions
of $7 billion to $10 billion per year. The United States is expected to announce
a $200 million commitment shortly.
How
the fund will be governed and operated remains very unclear.
One
possible starting point is a new, U.S.-initiated fund, housed at the World Bank.
The World Bank AIDS Trust Fund was created by Congressional action last year,
and the United States has allocated $20 million for the fund. This fund was
intended to galvanize international donations, but they have not materialized,
and some thought the fund would never get off the ground. However, Kofi
Annan’s proposal for a global fund sounded very similar to the World Bank AIDS
Trust Fund, leading some to think the World Bank entity would be revamped and
become the big global fund.
That
makes governance of the fund very important. The U.S. Treasury Department is in
charge of establishing the charter for the World Bank AIDS Trust Fund. The
Treasury Department’s proposal envisions a governing board made up of donors,
with some participation by recipient countries. “Donors” would include not
just governments, but private parties — meaning not just private foundations,
but private corporations E including the drug companies. Under the Treasury
Department proposal, for $5 million contributions, the drug companies would be
able to buy themselves seats on the Trust Fund’s governing board.
This
is a morally outrageous proposal. There are many parties to blame for the
horrible toll taken by the AIDS pandemic in poor countries (with as many as one
in three adults now HIV-positive in some African countries, and virtually all of
the HIV-positive people certain to die from AIDS unless treatment costs are
radically reduced), but the drug companies are hugely culpable. That they would
be permitted a key role in directing the world’s belated response to the
crisis dishonors the memories of the millions who have died preventable deaths
from HIV/AIDS.
Underlying
the moral argument are very practical considerations. Big Pharma participation
on the governing body of new global fund would create an irresolvable,
structural conflict of interest.
For
example, a crucial decision for the new fund will be whether it buys drugs at
best world prices, from multiple sources, including generics. The brand-name
companies are intent on excluding generics, and the brand-name companies
certainly should not have a role in the fund’s decision-making on this issue.
Suggestions
that the brand-name companies could simply recuse themselves from such issues
offer no solution. The brand-name companies should not be positioned to
influence fellow board members. And lots of decisions the board will make —
from matters relating to the mechanisms to deliver drugs, drug registration
rules, preferred drug regimens, and much more — will involve issues where drug
company conflicts will be pervasive, but may not be recognized.
If
Big Pharma wants to redeem itself and be “part of the solution” to the AIDS
pandemic, there is plenty it can do, starting with issuing licenses for its
HIV/AIDS drugs to the World Health Organization, which could then contract with
generic makers to provide cheap drugs for distribution in poor countries. But
putting the industry in charge, or partially in charge, of the primary global
response to HIV/AIDS — especially while the brand-name companies continue to
place enormous obstacles in the way of the generic competition that could make
AIDS drugs far more affordable and save millions of lives — would be
unconscionable.
Russell
Mokhiber edits the Corporate Crime
Reporter. Robert Weissman edits the Multinational
Monitor, and co-directs Essential Action, a corporate accountability group.
They are co-authors of Corporate
Predators: The Hunt for MegaProfits and the Attack on Democracy (Common
Courage Press, 1999). Focus on the Corporation columns are posted at www.corporatepredators.org
(c)
Russell Mokhiber and Robert Weissman. Reprinted with permission
HIV/AIDS:
General Assembly to hold special June session.
The
UN General Assembly will convene a special session from June 25 to 27, 2001 to
address the global HIV/AIDS epidemic. According to the assembly, the issue is
“a matter of urgency.”
In
a unanimous resolution, the General Assembly declared it will examine HIV/AIDS
in Africa, international funding and cooperation, the epidemic’s economic and
social impacts and human rights implications. The resolution also asks UN
Secretary-General Kofi Annan to submit a comprehensive report on the epidemic,
the international response and an analysis of long-term impacts.
In
addition, the resolution asks the General Assembly president to determine the
form and involvement of civil society in the special session. The assembly
specifically said people living with HIV/AIDS, nongovernmental organizations and
the business sector, including pharmaceutical companies, should be involved.
For
information, visit: http://www.un.org/ga/aids/,
or call (212) 963-6870, Fax: (212) 963-0536; email: pascale@un.org
![]()